PATENT CLAIM ANALYSIS

Application Number: 15862439
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "093200"]

Abstract:
Mutant  Listeria  bacteria that modulate interferon-β production are provided. The subject bacteria are characterized by having a mutation in a gene chosen from a TetR gene, a LadR gene, a VirR gene, a MarR gene a MdrL gene, a MdrT gene and a MdrM gene. The subject bacteria find use in a variety of applications, where representative applications of interest include, but are not limited to: (a) use of the subject bacteria as adjuvants; (b) use of the subject bacteria as delivery vectors for introducing macromolecules into a cell; (c) use of the subject bacteria as vaccines for eliciting or boosting a cellular immune response; etc.

Claim (Index 2):
The  Listeria  bacterium according to  claim 1 , wherein said mutation is a mutation in a transcription regulator gene.

Metadata:
- Claim Count in Document: 107.0
- Percentile: 86.0
- Lexical Diversity: 1.86567
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14103548', '13601814', '12514787', '14741107', '15192757']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8614585801466988
- 35 USC 102 Novelty (BERT): 0.7313046196160145
- Combined Prediction Score: 0.8484431840936304
- Mean Citation Score: 794.736494
- Max Citation Score: 801.7205
- Similarity Product: 798.3732632389665

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test